NCT02582749 Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases Status TERMINATED Phase PHASE2
NCT02577627 Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC Status UNKNOWN Phase N/A
NCT02573636 The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients with Biochemical Failure Status Post Salvage or Radical Radiation Therapy Status RECRUITING Phase N/A
NCT02572284 Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer Status COMPLETED Phase PHASE1
NCT02570919 Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer Status COMPLETED Phase NA
NCT02564549 MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca Status TERMINATED Phase NA
NCT02564120 North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) Status COMPLETED Phase N/A
NCT02559115 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer Status COMPLETED Phase PHASE2
NCT02555397 Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer Status COMPLETED Phase PHASE1
NCT02552394 J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts Status COMPLETED Phase PHASE1
NCT02551341 Lung Protective Ventilation During Robotic Assisted Prostatectomy Status COMPLETED Phase PHASE3
NCT02545881 Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness Status UNKNOWN Phase N/A
NCT02543905 The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment Status RECRUITING Phase N/A
NCT02543255 Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) Status COMPLETED Phase PHASE2
NCT02542501 Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues Status COMPLETED Phase N/A
NCT02538432 Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors Status WITHDRAWN Phase PHASE2
NCT02536014 Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial- Status COMPLETED Phase NA